Loading insider details...
Beta
Latest Form 4 (Jan 24, 2026): Grant/Award of 1,000,000 QNCX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 24, 2026 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 1,000,000 | n/a |
| Dec 12, 2025 | Quince Therapeutics, Inc. (QNCX) | Gift | 739,885 | n/a |
| Jun 23, 2025 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 150,944 | $181.1K |
| Feb 11, 2025 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 1,200,000 | n/a |
| Sep 3, 2024 | Quince Therapeutics, Inc. (QNCX) | Purchase | 77,500 | $53.5K |
| Feb 2, 2024 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 1,500,000 | n/a |
| Jan 17, 2024 | Quince Therapeutics, Inc. (QNCX) | Exercise/Conversion | 90,531 | $49.8K |
| Aug 11, 2023 | Quince Therapeutics, Inc. (QNCX) | Purchase | 88,000 | $110.9K |
| Aug 9, 2023 | Quince Therapeutics, Inc. (QNCX) | Purchase | 80,000 | $99.2K |
| Feb 2, 2023 | Quince Therapeutics, Inc. (QNCX) | Grant/Award | 600,000 | n/a |